Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce that its common ...

The final earnings release of 2024 finalized another difficult year for Tesla’s bottom line, as its full-year net income came in at $8.4 billion, a 23% decrease from 2023 and a 40% decline from 2022’s ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

JPMorgan updated its outlook on Nasdaq OMX Group Inc. (NASDAQ:NDAQ), increasing the price target to $95 from the previous $88, while reaffirming an Overweight rating on the stock. Currently trading at ...

Nvidia shares' 9% recovery Tuesday was the second-best day in terms of market cap added for any company ever—but the company ...

Detailed price information for JPM US Equity Premium Income ETF (JEPI-T) from The Globe and Mail including charting and trades.

We recently compiled a list of the 10 Extreme Dividend Stocks to Invest in Now. In this article, we are going to take a look ...

Ascentage Pharma Group (AAPG) (AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), has priced a $126M U.S. initial public offering. The China-based drug developer priced 7.33M shares at $17.25 ...

We recently published a list of 12 Best Dow Stocks to Buy Right Now. In this article, we are going to take a look at where ...

Morgan Stanley’s stock outpaced gains in other financial stocks Thursday, after the bank and broker forecast a robust flow of deals as it beat both profit and revenue expectations for the latest ...

Flowco Holdings Inc. ("Flowco"), a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry, today announced the closing of its initial ...